SAB Biotherapeutics, Inc. (SABS)
NASDAQ: SABS · Real-Time Price · USD
3.510
+0.010 (0.29%)
Sep 18, 2026, 4:00 PM EDT - Market closed
SAB Biotherapeutics Financials Overview
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Fiscal Quarter | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Sep '21 Sep 30, 2021 |
Revenue Revenue Growth | - | - | - | - | - | - | 0.11 | - | 0.26 | 0.94 | 0.31 | 1.27 | 0.09 | 0.58 | 2.16 | 3.59 | 6.35 | 11.8 | 11.06 | 14.68 |
Revenue Growth | - | - | - | - | - | - | -62.40% | - | 207.70% | 62.55% | -85.89% | -64.70% | -98.65% | -95.08% | -80.46% | -75.55% | -65.13% | -30.27% | -57.06% | -15.96% |
Gross Profit Gross Profit Growth | -16.17 | -13.4 | -9.73 | -8.97 | -7 | -7.66 | -6.84 | -7.83 | -6.56 | -7.2 | -3.99 | -2.75 | -3.58 | -3.95 | -4.98 | -3.76 | -2.23 | -1.52 | 0.41 | -0.39 |
Operating Income Operating Income Growth | -23.38 | -20 | -15.77 | -12.68 | -9.73 | -10.77 | -10.01 | -11.31 | -10.2 | -11.39 | -18.87 | -5.32 | -6.48 | -7.4 | -7.86 | -7.81 | -6.54 | -6.71 | -7.34 | -3.99 |
Net Income Net Income Growth | -22.49 | -18.87 | -2.85 | 5.34 | -10.11 | -5.2 | -11.39 | -10.35 | -7.34 | -5.03 | -22.86 | -5.1 | -6.88 | -7.35 | -7.87 | -7.08 | -4.78 | 0.99 | -11.55 | -4.06 |
Earnings Per Share EPS Growth | -0.28 | -0.35 | -0.25 | -0.21 | -1.09 | -0.56 | -1.23 | -1.12 | -0.79 | -0.54 | -3.38 | -0.97 | -1.36 | -1.46 | -1.75 | -1.64 | -1.11 | 0.20 | -3.70 | -1.56 |
EPS Growth | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -60.00% | - | - |
| Fiscal Quarter | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Sep '21 Sep 30, 2021 |
Cash & Investments Cash & Investments Growth | 102.63 | 107.39 | 96.59 | 110.88 | 5.71 | 12.85 | 20.76 | 30.4 | 37.33 | 44.06 | 56.57 | 2.43 | 7.77 | 13.06 | 15.05 | 8.33 | 16.62 | 22.41 | 33.21 | 10.75 |
Total Debt Total Debt Growth | 5.13 | 6.17 | 5.95 | 6.19 | 6.42 | 6.78 | 4.67 | 4.52 | 5.34 | 5.45 | 5.91 | 4.65 | 4.9 | 5.46 | 5.93 | 5.8 | 6.09 | 6.41 | 8.52 | 6.82 |
Net Cash (Debt) Net Cash Growth | 97.5 | 101.22 | 90.64 | 104.69 | -0.71 | 6.07 | 16.09 | 25.88 | 31.98 | 38.61 | 50.66 | -2.23 | 2.87 | 7.6 | 9.12 | 2.53 | 10.53 | 16 | 24.69 | 3.93 |
Net Cash Growth | - | 1568.24% | 463.28% | 304.53% | - | -84.28% | -68.23% | - | 1014.26% | 408.01% | 455.59% | - | -72.73% | -52.49% | -63.07% | -35.66% | 217.39% | 256.69% | 450.61% | - |
Net Cash Per Share Net Cash Per Share Growth | 1.22 | 1.89 | 1.89 | 1.34 | -0.08 | 0.65 | 1.73 | 2.80 | 3.46 | 4.18 | 7.49 | -0.42 | 0.57 | 1.51 | 2.03 | 0.59 | 2.45 | 3.49 | 7.85 | 1.51 |
| Fiscal Quarter | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Sep '21 Sep 30, 2021 |
Operating Cash Flow Operating Cash Flow Growth | -9.84 | -14.27 | -16.78 | -13.05 | -7.15 | -7.8 | -9.53 | -6.29 | -7.72 | -10.75 | -13.45 | -5.17 | -4.9 | -1.61 | -1.56 | -7.92 | -4.45 | -9.54 | -4.88 | 3.8 |
Capital Expenditures CapEx Growth | -1.59 | -0.98 | -0.93 | - | - | - | -0.06 | -0.1 | -0.05 | -0.13 | -0.07 | -0.09 | -0.02 | -0.02 | -0.12 | -0.08 | -0.61 | -1.36 | -2.36 | -3.23 |
Free Cash Flow Free Cash Flow Growth | -11.43 | -15.25 | -17.71 | -13.05 | -7.15 | -7.8 | -9.59 | -6.39 | -7.77 | -10.88 | -13.51 | -5.25 | -4.92 | -1.63 | -1.67 | -8 | -5.06 | -10.9 | -7.24 | 0.57 |
Free Cash Flow Growth | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Fiscal Quarter | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Sep '21 Sep 30, 2021 |
Gross Margin | - | - | - | - | - | - | - | - | - | - | - | -217.17% | - | - | -230.34% | -104.83% | -35.18% | -12.89% | 3.71% | -2.65% |
Operating Margin | - | - | - | - | - | - | -8726.26% | - | -3876.95% | -1205.90% | -6187.90% | -420.00% | -7573.40% | -1273.79% | -363.74% | -217.49% | -103.03% | -56.83% | -66.41% | -27.18% |
Pretax Margin | - | - | - | - | - | - | -9934.52% | - | -2787.69% | -532.06% | -7493.75% | -402.59% | -8046.13% | -1265.50% | -363.23% | -197.12% | -76.66% | 9.13% | -104.46% | -27.66% |
Profit Margin | - | - | - | - | - | - | -9934.52% | - | -2787.69% | -532.06% | -7493.75% | -402.59% | -8046.13% | -1265.50% | -364.42% | -197.12% | -75.21% | 8.35% | -104.46% | -27.66% |
FCF Margin | - | - | - | - | - | - | -8358.96% | - | -2952.95% | -1151.74% | -4430.85% | -414.49% | -5755.33% | -279.99% | -77.41% | -222.78% | -79.69% | -92.31% | -65.47% | 3.88% |
| Fiscal Quarter | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Sep '21 Sep 30, 2021 |
PS Ratio | - | - | - | - | - | - | 26.48 | - | 10.29 | 16.09 | 28.33 | 8.05 | 6.52 | 1.75 | 1.24 | 0.92 | 1.42 | 2.90 | 5.58 | 1.97 |